ICOAT MEDICAL Trademark

Trademark Overview


On Thursday, June 8, 2023, a trademark application was filed for ICOAT MEDICAL with the United States Patent and Trademark Office. The USPTO has given the ICOAT MEDICAL trademark a serial number of 79378210. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, November 5, 2024. This trademark is owned by iCoat Medical AB. The ICOAT MEDICAL trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Chemical preparations for medical or veterinary purposes, namely, pharmaceutical preparations used for the treatment of blood supply flow disorders, transfusion and infusion of blood components, inflammation, thrombosis, blood clotting disorders, instant blood mediated reaction (IBMIR), stroke, myocardial infarction, immunosuppressant disorders and immune system rejection; chemical preparations for medical and veterinary purposes, namely, for treatment of cells, cell transplants and organ transplants; chemical preparations for medical and veterinary purposes, namely protecting organs from damage in connection with transplantation, for reducing ischemia-reperfusion injury, for protection of ischemic cells against attacks by the immune system, for protecting the peritoneum in connection with dialyses and for reduction of the risk of or protection against thromboinflammation, rejection of organs, organ or cell transplant rejection, hyperacute rejection of organs, and antibody-mediated rej...

Medical services, information and consultancy in the fields of organ transplantation, ischemia-reperfusion injury, thromboinflammation, rejection of organs, organ or cell transplant rejection, hyperacute rejection of organs, antibody-mediated rejection of organs and organ tissue damage

Research services and development in the fields of organ transplantation, ischemia-reperfusion injury, thromboinflammation, rejection of organs, organ or cell transplant rejection, hyperacute rejection of organs, antibody-mediated rejection of organs and organ tissue damage
icoat medical

General Information


Serial Number79378210
Word MarkICOAT MEDICAL
Filing DateThursday, June 8, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, November 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 5, 2024

Trademark Statements


Goods and ServicesChemical preparations for medical or veterinary purposes, namely, pharmaceutical preparations used for the treatment of blood supply flow disorders, transfusion and infusion of blood components, inflammation, thrombosis, blood clotting disorders, instant blood mediated reaction (IBMIR), stroke, myocardial infarction, immunosuppressant disorders and immune system rejection; chemical preparations for medical and veterinary purposes, namely, for treatment of cells, cell transplants and organ transplants; chemical preparations for medical and veterinary purposes, namely protecting organs from damage in connection with transplantation, for reducing ischemia-reperfusion injury, for protection of ischemic cells against attacks by the immune system, for protecting the peritoneum in connection with dialyses and for reduction of the risk of or protection against thromboinflammation, rejection of organs, organ or cell transplant rejection, hyperacute rejection of organs, and antibody-mediated rejection of organs
Goods and ServicesMedical services, information and consultancy in the fields of organ transplantation, ischemia-reperfusion injury, thromboinflammation, rejection of organs, organ or cell transplant rejection, hyperacute rejection of organs, antibody-mediated rejection of organs and organ tissue damage
NOT AVAILABLEMEDICAL
Goods and ServicesResearch services and development in the fields of organ transplantation, ischemia-reperfusion injury, thromboinflammation, rejection of organs, organ or cell transplant rejection, hyperacute rejection of organs, antibody-mediated rejection of organs and organ tissue damage

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 8, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 8, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 8, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameiCoat Medical AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSE

Party NameiCoat Medical AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSE

Trademark Events


Event DateEvent Description
Thursday, September 7, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, September 8, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 12, 2023APPLICATION FILING RECEIPT MAILED
Saturday, February 3, 2024NEW REPRESENTATIVE AT IB RECEIVED
Thursday, February 29, 2024ASSIGNED TO EXAMINER
Monday, March 11, 2024NON-FINAL ACTION WRITTEN
Friday, March 29, 2024REFUSAL PROCESSED BY MPU
Wednesday, April 24, 2024REFUSAL PROCESSED BY IB
Tuesday, September 24, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 24, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 24, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 12, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, March 29, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, September 25, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 16, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 5, 2024PUBLISHED FOR OPPOSITION
Tuesday, November 5, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED